Here, we hypothesize that the measles, mumps, and rubella MMR vaccine could provide a broad neutralizing antibody against numbers of diseases, including COVID 19. Our hypothesis is based on the 30 amino acid sequence homology between the SARS CoV 2 Spike S glycoprotein